Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. Treatment Improvement Protocol (TIP) Series 43
This publication gives a detailed description of medication-assisted treatment for addiction to opioids, including comprehensive maintenance treatment, detoxification, and medically supervised withdrawal. Discusses screening, assessment, and administrative and ethical issues.
In My Own Words... A compilation of essays by individuals supported by Medication-Assisted Treatment in long-term recovery
In recognition of the 2011 National Recovery Month, the ATTC National Office, in partnership with Faces & Voices of Recovery and the National Alliance for Medication Assisted (NAMA) Recovery, sponsored the 4th annual "In My Own Words …" Essay Contest and invited individuals who have been supported by Medication-Assisted Treatment (MAT) to share their own story of recovery. In their own words, they were asked to describe the most challenging part about MAT and explain why they are committed to recovery. The top 20 essays are presented in the compilation.
Mid-America ATTCs Psychotherapeutic Medications 2011: What Every Counselor Should Know
Psychotherapeutic Medications 2011: What Every Counselor Should Know was originally developed as a companion piece to the Mid-America ATTC systems change curriculum, A Collaborative Response: Addressing the Needs of Consumers with Co-Occurring Substance Use and Mental Health Disorders. This booklet is an excellent reference document for clinicians, containing information on generic and brand names, their purpose, usual dose and frequency, side effects, potential for abuse and dependence, emergency conditions, and cautions.
SAMHSA Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence
This issue gives an overview of extended-release injectable naltrexone (Vivitrol), a treatment for people with opioid dependence. Discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit from this treatment.
SAMHSA Brochure: Medication-Assisted Treatment for Opioid Addiction: Facts for Family and Friends
This 16-page booklet provides basic information about medication-assisted treatment for opioid addiction. It describes medication options, the proper use of the medications, and common side effects. The booklet is directed at families and friends of patients entering medication-assisted treatment for opioid addiction. Also available in Spanish.
Effective Strategies in Assessing Individual Impairment in Outpatient Methadone Treatment
This CD covers issues related to the specific topic of assessing individual "impairment" in outpatient methadone treatment. This topic is particularly challenging to many who provide opioid pharmacotherapy treatment in general, and methadone treatment in specific.
Effective Strategies in Outpatient Methadone Treatment - Clinical Guidelines and Liability Prevention
Conducted by experts in insurance, law, policy, and daily clinical practices, this curriculum provides the framework for applying best practices and developing comprehensive risk management strategies that improve patient safety and enable OTPs and methadone maintenance programs to eliminate, transfer, reduce, and manage the risks associated with medication-assisted treatment for opioid dependence.
Monograph: Recovery Oriented Methadone Maintenance
There are growing calls to shift the acute-care model of addiction treatment to a model of sustained recovery support analogous to the long-term management of other chronic diseases. The purpose of this monograph is to explore what this shift means to the design and delivery of methadone maintenance (MM) treatment and the status of MM treatment and MM patients in the United States.
NIATx: Getting Starting with Medication-Assisted Treatment with Lessons from Advancing Recovery
The goal of the grant was to promote the use of evidence-based practices such as MAT through innovative partnerships between state agencies and treatment organizations. This toolkit shares lessons that emerged from the efforts of several of the grantees to establish MAT programs in their organizations.
TAP 30: Buprenorphine: A Guide for Nurses
This Guide gives nurses information about buprenorphine for medication-assisted treatment of addiction to opioids and guidelines for working with physicians to provide office-based screening, assessment, supervised withdrawal (detoxification), and maintenance treatment
SAMHSA Brochure: The Facts About Buprenorphine for Treatment of Opioid Addiction
This booklet provides basic information about the use of buprenorphine in medication-assisted treatment for opioid addiction. It describes how buprenorphine works, the proper use of the medication, and common side effects. The booklet is directed at patients entering medication-assisted treatment for opioid addiction, and it may be useful to patients' family members and friends. Also available in Spanish
SAMHSA Brochure: The Facts About Naltrexone for Treatment of Opioid Addiction
This booklet provides basic information about the use of naltrexone in medication-assisted treatment for opioid addiction. It describes how naltrexone works, the proper use of the medication, and common side effects. The booklet is directed at patients entering medication-assisted treatment for opioid addiction, and it may be useful to patients' family members and friends. Also available in Spanish
SAMHSA's Partners for Recovery Brochure: Know Your Rights: Rights for Individuals on Medication-Assisted Treatment
This brochure aims to reduce discrimination by giving people in MAT (and their advocates) basic information necessary to exercise their rights or, at a minimum, know where to turn for help. It also seeks to reduce discrimination by educating those who might discriminate (e.g., employers, housing providers, and government agencies) about such laws, as well as about MAT itself.
Profiles each state's certified opioid treatment programs and physicians certified to practice medication-assisted therapy for opioid addiction. Provides data on the number of patients, treatment type (maintenance and/or detoxification), and accreditation.